Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 20.2.2025MEDOCHEMIE Ltd. (MOE)39638ALMIRAL GEL (gel 1x100 g (tuba Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)67517MEDOCIPRIN 250 mg (tbl flm 10x250 mg (blis.PVC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)65111MEDOCLAV 1,2 g (plo ijf 10x1,2 g (liek.inj.skl.))17.2.2025R
 20.2.2025MEDOCHEMIE Ltd. (MOE)53504RAMIMED 10 mg (tbl 30x10 mg (blis.Al/Al/PA/PVC))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)67525ANARGIL 100 mg (cps dur 100x100 mg (blis.PVC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)34922MEDOFLOXINE 200 mg (tbl flm 20x200 mg (blis.PVC/Al))17.2.2025R
 20.2.2025MEDOCHEMIE Ltd. (MOE)67031MEDOFLUCON 150 mg (cps dur 10x150 mg (blis.PVC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)67563Dapril 20 mg (tbl 20x20 mg (blis.PVC/PVDC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)3671CMEDOCLAV 400 mg/5 ml + 57 mg/5 ml prášok na perorálnu suspenziu (plu por 1x70 ml (fľ.skl.hnedá+dáv.striek.))17.2.2025R
 20.2.2025MEDOCHEMIE Ltd. (MOE)33199MEDOFLUCON 50 mg (cps dur 100x50 mg (blis.PVC/Al))17.2.2025O
 20.2.2025B.Braun Melsungen AG (BME)34254Glukóza B. Braun 5 % infúzny roztok (sol inf 10x500 ml (fľ.LDPE))20.2.2025R
 20.2.2025IMUNA PHARM, a.s. (IMA)3463CChlorid sodný 0,9 % IMUNA ENVIBAG (sol inf 1x500 ml (vak PP-infúzny s inf.a inj.portom))14.2.2025O
 20.2.2025IMUNA PHARM, a.s. (IMA)3462CChlorid sodný 0,9 % IMUNA ENVIBAG (sol inf 1x250 ml (vak PP-infúzny s inf.a inj.portom))31.1.2025O
 20.2.2025Neuraxpharm Bohemia s.r.o. (NUA)6820BRopinirol Neuraxpharm 8 mg (tbl plg 84x8 mg (fľ.HDPE))20.2.2025R
 20.2.2025Neuraxpharm Bohemia s.r.o. (NUA)1087DDuoxona 40 mg/20 mg tablety s predĺženým uvoľňovaním (tbl plg 60x40 mg/20 mg (blis.Al/PVC/PE/PVDC))12.1.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To